Tradestie Institutional Equity Comparison Engine
NTLA vs AMLX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AMLX Overall Edge
AMLX Captures Institutional Edge (4โ0 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus AMLX at 2.8x Forward P/E and 0.0% operating margin (-99.6% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against AMLX sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
AMLX
NTLA N/M vs AMLX 2.8x Fwd P/E
Growth & Margin Winner
AMLX
Op Margin -826.0% vs 0.0% ยท YoY -48.0% vs -99.6%
Momentum & Technical Winner
AMLX
1Y +15.3% vs +127.3% ยท 52W Pos 20% vs 57%
Options & Structure Winner
AMLX
BREAKDOWN (78th %ile IV) vs BREAKDOWN (10th %ile IV)
NTLA
NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap
$1.5B
1M Return
-12.43%
1Y Return
+15.34%
Forward P/E
N/M
Unified AI Score
49.9 / 100
HOLD
Tech 47.0
Fund 55.0
Flow 59.0
Mom 60.0
AMLX
NASDAQ
Amylyx Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.23
-6.78% 1D
Market Cap
$3.8B
1M Return
+7.19%
1Y Return
+127.33%
Forward P/E
2.8x
Unified AI Score
58.8 / 100
HOLD
Tech 47.0
Fund 52.0
Flow 64.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NTLA +15.34%
AMLX +127.33%
Spread: +111.99 pp (AMLX Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NTLA Revenue | AMLX Revenue | NTLA Op. Margin | AMLX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $30M | N/A | -298.6% | N/A | NTLA |
| FY2019 | $40M | N/A | -246.8% | N/A | NTLA |
| FY2020 | $60M | N/A | -235.5% | N/A | NTLA |
| FY2021 | $30M | $0M | -810.4% | -29013.3% | NTLA |
| FY2022 | $50M | $20M | -879.0% | -905.7% | NTLA |
| FY2023 | $40M | $380M | -1420.5% | 10.2% | AMLX |
| FY2024 | $60M | $90M | -923.1% | -360.2% | AMLX |
| FY2025 | $70M | N/A | -651.7% | N/A | NTLA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NTLA | AMLX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.5B | $3.8B | Larger Scale | AMLX |
| Trailing P/E Ratio Valuation | N/M | 2.8x | Lower Multiple | AMLX |
| Forward P/E Ratio Valuation | N/M | 2.8x | Lower Multiple | AMLX |
| Revenue Growth (YoY) Growth | -48.0% | -99.6% | Higher Growth | NTLA |
| Operating Margin (TTM) Profitability | -826.0% | 0.0% | Higher Margin | AMLX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -62.6% | -30.1% | Higher ROE | AMLX |
| 52-Week Range Position Momentum | 20% ($8โ$18) | 57% ($11โ$41) | Stronger Trend | AMLX |
| Beta / 30D Volatility Risk Regime | 2.30ฮฒ ยท 87% Vol | 1.16ฮฒ ยท 59% Vol | Lower Realized Risk | AMLX |
| Unified Institutional Score Composite Signal | 49.9 / 100 (HOLD) | 58.8 / 100 (HOLD) | Higher Composite | AMLX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NTLA vs AMLX Buy Guide
NTLA
BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
78th %ile
IV Regime
Elevated (60thโ80th %ile)
AMLX
BREAKDOWN
61d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NTLA nor AMLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.